Geoffrey Falkson, South African oncologist and chemotherapist (Pretoria 09 August 1932 – 10 January 2019)
Authored over 400 papers
Demonstrated the potentiation of ionizing radiation and fluorinated pyrimidines in the treatment of gastrointestinal cancer
Fluorinated pyrimidine as potentiators of ionizing radiations in the treatment of stomach cancer in man. Thesis (1964)
SOME BIBLIOGRAPHY
With A.M. Chedid, L.M. Ryan, Y. Dayal & B.C. Wolf. Morphology and other prognostic factors of hepatocellular carcinoma. Arch. Pathol. Labor. Medic. 123(6):524-8, 1999
With J.I. Raats & H. Falkson. Fadrozole hydrochloride, a new nontoxic aromatase inhibitor for the treatment of patients with metastatic breast cancer. J. Ster. Biochem. Mol. Biol. 43:161-5, 1992
With C. Falkson & H. Falkson. Improved results with the addition of interferon alpha 2a to dacarbazine in the treatment of patients with metastatic malignant melanoma. J. Clin. Oncol. 9:1043-8, 1991
With H.C. Falkson & C.I. Falkson. High versus low dose granisetron, a selective 5HT3 antagonist, for the prevention of chemotherapy-induced nausea and vomiting. Investig. Drugs 8:407-9, 1990
With H.C. Falkson & C.I. Falkson. The effect of chemotherapy with or without GnRHA on serum hormone levels in premenopausal women with breast cancer. Proc. Am. Soc. Clin. Oncol. 9:25, 1990
With H.C. Falkson, A. Cnaan, A.J. Schutt & L.M. Ryan. Prognostic factors for survival in nhepatocellular carcinoma. Cancer Res. 48:7314-8, 1988
High-dose medroxyprogesterone acetate plus mitomycin-C or vindesine in the treatment of advanced breast cancer. Am. J. Clin. Oncology - Cancer Clin Trials 2:431-4, 1988
With R.S. Gelman & F.J. Pretorius. Age as a prognostic factor in recurrent breast cancer. J. Clin. Oncol. 4(5):663-71, 1986
With B. Klein & H. Falkson. Hematological toxicity: experience with anthracyclines and anthracenes. Exp. Hematol. 13:64-71, 1985 (Suppl. 16)
With J.M. McIntyre, A.J. Schutt, B.J. Coetzer et al. Neocarzinostatin versus m-AMSA or adriamycin in hepatocellular carcinoma. J. Clin. Oncol. 2:581-4, 1984
With D.A. Vorobiof, J.H. Lerner et al. A phase II study of M-AMSAin patients with malignant mesothelioma. Cancer Chemotherap. Pharmacol. 11:94-7, 1983
With H.C. Falkson & I.W. Simson. Non-Hodgkin’s lymphoma in pregnancy. Cancer 45:1679-82, 1980
Chemotherapy studies in primary liver cancer: a prospective randomized clinical trial. Cancer 42(5):2149-56, 1978
With H.C. Falkson. Further experience with isophosphimide (1976)
With H.C. Falkson. Fluorouracil, methyl-CCNU and vincristine in cancer of the colon. Cancer 38:1468-70, 1976
Therapeutic approaches to hepatoma. Cancer Treat. Rev. 2:73-6, 1975
With E.G. Van Edin & H.C. Falkson. Fluorouracil midazole carboxamide dimethyltriazeno, vincristine and bischloroethylintrourea in colon cancer. Cancer 33:1207, 1974
With J.J. Van Dyck, H.C. Falkson & A.M. Van der Merwe. Unexpected toxicity in patients treated with iphosphamide. Cancer Res. 32:921-4, 1972
An annotation on the treatment of disseminated breast cancer in premenopausal women. S. Afr. J. Surg. 10:41-4, 1972
With E.W. Geddes. Malignant hepatoma in the Bantu. Cancer 25(6):1271-8, 1970
Behandeling van Gevorderde Longkanker. Geneeskunde 11:147, 1969
With H.C. Falkson. Erythroleukemia. S. Afr. Med. J. 42:1291, 1968
With H.C. Falkson. The clinical testing of anti-cancer drugs and the criteria for response to these drugs. S. Afr. Cancer Bull. 10:5, 1966
With E.J. Schulz. Skin changes caused by cancer chemotherapy. Br.J. Dermatol. 76:309-14, 1964
With H.J. Snyman. Experience with chemotherapy of cancer at the University of Pretoria. Acta Union Int. Contre Le Cancer 20:439-66, 1964
With E.J. Schulz. Endoxan alopecia. Br.J. Dermatol. 72:296-301, 1960
Chemotherapie van Primere Lewerkarsinoom. Spekulum 3:5-11, 1959
HONOURS
Special Award for Meritorius Service, Eastern Cooperative Oncology Group, United States (1997)
International Award of Imminent Scientist of the Decade 1990-99